Mar 21, 2023
Highp, the pioneering provider of next-generation video communication and customer consent management platforms, is thrilled to announce a new licensing agreement with Exeltis, a rapidly growing multinational pharmaceutical organization committed to innovation and women's health. This new agreement is a continuation of their successful 2022 contract, which has helped Exeltis improve engagement rates threefold.
The collaboration between Highp and Exeltis has resulted in significant improvements in communication about Exeltis therapies to healthcare professionals. Highp's team, partnering with business trainers, has been working closely with Exeltis to continuously enhance their communication efforts, ensuring healthcare professionals receive the most up-to-date and relevant information about their therapies.
Highp's video messaging platform offers key advantages over traditional text messaging, SMS, and MMS. These differences include:
Richer, more engaging content: Highp's video messages provide a more immersive and interactive experience for recipients, which leads to increased engagement and better information retention.
Personalization: Highp's platform allows for the creation of tailored video messages to address the specific needs and preferences of healthcare professionals, leading to a more impactful communication experience.
Analytics and insights: Highp's advanced analytics provide valuable data on recipient engagement, allowing Exeltis to make data-driven decisions and continuously improve their communication strategies.
Enhanced security and compliance: Highp's platform is designed to meet the stringent security and compliance requirements of the pharmaceutical industry, ensuring that sensitive information is protected and communications meet all relevant regulatory guidelines.
Igor Gnot, CEO Connectmedica (Highp) said, "We are excited to continue our collaboration with Exeltis and support their efforts to bring the best communication about their therapies to healthcare professionals. The impressive improvements in engagement rates demonstrate the power of Highp's video messaging platform in transforming the way pharmaceutical companies interact with their audience."
Tomasz Slaski, General Manager Exeltis added, "Our ongoing partnership with Highp has been instrumental in elevating our communication strategies, allowing us to more effectively reach healthcare professionals and provide them with the information they need. We look forward to further leveraging Highp's innovative technology and expertise in the years to come."
Highp is a leading provider of next-generation video communication, customer consent management, and remote presentation platforms, specifically designed for the pharmaceutical and life science industries. With a mission to revolutionize the digital health sector, Highp delivers innovative solutions that empower healthcare providers to engage with their customers in a more efficient, personal, and secure manner. For more information about Highp, visit https://highp.me.
Exeltis is a rapidly growing multinational pharmaceutical organization dedicated to innovation and women's health. With a presence in over 40 countries, Exeltis leverages its expertise in research, development, manufacturing, and marketing to bring life-changing treatments to healthcare professionals and patients around the world. For more information about Exeltis, visit https://exeltis.com/en/who-we-are/.
Global biopharmaceutical company Bristol Myers Squibb contin...
Our client wins and remains at the top of the Share of Voice...